Tendinitis Treatment Industry to Worth USD 13,099.0 million | Along with Eminent Players like Abbott, Pfizer, AstraZeneca, Bayer, Merck & others

Tendinitis Treatment - Market Scenario:

Tendinitis is a disease in which the tendons become inflamed. This disease is also known as tendonitis. Tendinitis can occur due to sports activities or activities like gardening, painting, scrubbing, carpentry, etc. It can also be caused due to calcium deposits near the tendons. Most commonly it is caused due to prolonged stress or subsequent wear and tear caused by repetitive movements.

Additionally, it can also be caused due to sudden trauma. Most people suffer from tendonitis while performing their daily jobs or enjoying hobbies or indulging in sports activities. Since, tendons become less flexible as the age increases, tendonitis can also be developed with age. Symptoms of tendinitis include pain, swelling, stiffness, and restricted mobility at the affected joint, muscle weakness and affected skin can feel warm over the surface. Anyone can suffer from this condition but the people above the age of 40 are more likely to suffer from Tendinitis.

Request for sample Report at https://www.marketresearchfuture.com/sample_request/5227

Tendinitis can occur in any part of the body. Most common areas can be knees, elbows, shoulders, hips, base of the thumb and Achilles tendon. When a person suffers from Tendinitis, he/she faces rising pain and/or frozen shoulder. It can be treated using physiotherapy, corticosteroid injections and surgery. In addition to this, tendinitis can be treated by rest, and OTC (Over the Counter) pain relieving medicines. The condition can be diagnosed directly through the physical exam.

Increasing cases of sports injuries, growing geriatric population, increasing cases of people suffering from diabetes and rheumatoid arthritis are the factors expected to drive the Tendinitis treatment market in Americas and Europe. According to a report published by the American Academy of Physical Medicine and Rehabilitation in 2014, 25 to 50% cases of sport injuries in the US are due to overuse of hand and wrist. Side effects of the treatment are likely to restrain the market. For instance, use of NSAIDs (Non-Steroidal Inflammatory Drugs) resulting in stomachache and gastrointestinal bleeding.

The market in Americas & Europe is expected to grow at a CAGR of 7.2% during the forecast period of 2017 to 2023 and estimated to reach at USD 13,099.0 million by 2023 from USD 7,525.3 in 2016.

Tendinitis Treatment Market – Competitive Landscape

The global tendinitis treatment market is observed to be growing rapidly owing to increasing developments of key players like Pfizer Inc., Abbott, AstraZeneca, Bayer AG, Merck & Co. Inc., GlaxoSmithKline plc, Teva Pharmaceuticals Industries Ltd. and Boehringer Ingelheim Pharmaceuticals Inc. which boosts the market growth.

Check Discount Here at https://www.marketresearchfuture.com/check-discount/5227

The key players in the market have adopted strategy to sustain its position in the global market through use of advanced technology to develop drugs for the treatment of Tendinitis.

In May 2017, Pfizer announced US FDA filing acceptance of supplemental new drug application (NDA) for Xeljanz for the treatment of patients suffering with active psoriatic arthritis, a chronic inflammatory multisystem disease caused due to various reasons including persistent painful tendonitis.

In August 2016, Teva Pharmaceuticals Industries Ltd. acquired Actavis Generics. This acquisition made Teva’s Generics and specialty business stronger.

Regional Analysis:

The American region is expected to be the leading region in the tendinitis treatment market due to the rising demand for new treatment options for tendinitis and rising cases of sport injuries and ailments such as arthritis. On regional basis, American region is divided into North America and South America. North America is expected to dominate the market due to presence of developed countries like the US and Canada. Additionally, development of sports medicines in the less developed and developed regions of America is boosting this market. According to the Center for Disease Control and Prevention, 26% people in the US aged more than 18 years will have medically diagnosed arthritis by 2040. Also, Tendinitis cases among the athletes in US have been increasing in the past few years which is likely to contribute to the market growth.

Europe is anticipated to be the second leading market for tendinitis treatment due to increasing prevalence of diabetes and rheumatoid arthritis. Availability of funds for R&D activities in medical devices will boost the demand for technologically advanced devices that help in the diagnosis of tendinitis. Lifestyle changes and minimal physical activity is boosting the growth of this market. European market is divided into two segments – Western Europe and Eastern Europe. Western Europe is expected to hold the largest market share in the European region. Within Western Europe, Germany is anticipated to lead the market due to innovative product development and rapid adoption of new treatments.

Ask Any Question at https://www.marketresearchfuture.com/enquiry/5227

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.